Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|February 13, 2001
The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancerF Grossi, T Scolaro, L Tixi, et al.
Cytotechnology|January 1, 1996
Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patientsA Guglielmi, C Aschele, F Grossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1999
The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC)A Ardizzoni, G Antonelli, F Grossi, et al.
Drugs|February 17, 1998
Management of malignant pleural effusionsF Grossi, M C Pennucci, L Tixi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracilA Mori, S Bertoglio, A Guglielmi, et al.
Anticancer Research|January 30, 2003
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancerF Grossi, M C Pennucci, J Serrano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerA Sobrero, M T Nobile, A Guglielmi, et al.
British Journal of Cancer|September 25, 1999
Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancerA Ardizzoni, F Grossi, T Scolaro, et al.
British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Pageof 1